Current and Future Immunotherapy Approaches for HCC: Evidence, Guidance, and Resources

Download All
This comprehensive program features expert hepatologist and medical oncologist perspectives on the evolving immunotherapy landscape for HCC, with a focus on multidisciplinary best practices for managing your patients. Watch an on-demand Webcast from a live activity, listen to podcasts, and download the slides for discussion with your colleagues.
Lipika Goyal, MD
David Kaplan, MD, MSc
person default
Thomas Karasic, MD
Amit G. Singal, MD, MS

On-Demand Webcast

Watch this on-demand Webcast featuring an expert presentation on the use of checkpoint inhibitors in patients with advanced hepatocellular carcinoma. This program specifically focuses on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: No longer available for credit

Watch this on-demand webcast featuring an expert presentation on the use of checkpoint inhibitors in patients with advanced hepatocellular carcinoma. This program specifically focuses on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team.

David Kaplan, MD, MSc person default Thomas Karasic, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 21, 2021 Expired: June 20, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue